The Food and Drug Administration is shifting its annual COVID-19 vaccine approval policies to focus on Americans older than age 65 and other "high-risk" individuals, while increasing the standard of evidence to approve COVID vaccines for low-risk individuals.
The Food and Drug Administration says it has decided to continue approving COVID-19 vaccine updates for seniors and others at higher risk of severe disease, but will require vaccine makers to conduct ...
Twenty people, a mental health business and a church were charged in an indictment that alleged Arizona’s Medicaid program was defrauded $60 million in a scheme involving billing for mental health tre...